MedTrace Logo

Effect of Adding Dexamethasone to Bupivacaine in Ultrasound-Guided Supraclavicular Brachial Plexus Blocks Versus Bupivacaine Alone for Upper Limb Orthopaedic Surgery

NCT07399691 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2026-02-10

No results posted yet for this study

Summary

* SCBPBs provides optimal conditions for procedures performed below the mid-upper arm (elbow, forearm, wrist, hand) due to its high success rate and ease of access.
* Dexamethasone, when administered perineurally as an adjuvant for a supraclavicular block, demonstrated early onset of sensory and motor block, a prolonged duration of sensory and motor block, and a lower number of rescue analgesics as compared to bupivacaine alone.
* A combination of dexamethasone and bupivacaine is paramount in adult orthopeadic patient to enhance the efficacy of pain management under ultrasound-guided supraclavicular brachial plexus block.

Conditions

  • Dexamethasone
  • Bupivacaine
  • Upper Limb Surgery

Interventions

DRUG

Dexamethasone 8 mg

Adding 8 mg of dexamethasone to bupivacaine for ultrasound-guided supraclavicular block

Sponsors & Collaborators

  • Arsi University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • Ethiopia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07399691 on ClinicalTrials.gov